Markets:

Overview

News

Currencies

International

Treasuries

QuidelOrtho Corporation - Common Stock (NQ:QDEL)

33.95 +0.44 (+1.30%)

Streaming Delayed Price Updated: 12:19 PM EST, Jan 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about QuidelOrtho Corporation - Common Stock

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

The Signs, Diagnosis and Treatment of Lyme Disease Discussed as Part of New, On-Demand Webinar Hosted by Industry-Leading Quidel Corporation

January 05, 2022

The Signs, Diagnosis and Treatment of Lyme Disease Discussed as Part of New, On-Demand Webinar Hosted by Industry-Leading Quidel Corporation

Via News Direct

Quidel to Present at 40th Annual J.P. Morgan Healthcare Conference

January 04, 2022

From Quidel Corporation

Via Business Wire

Bulls Should Begin 2022 With A Win ↗

January 03, 2022

The first trading day of the new year is seasonally very strong by a number of studies and that is reinforced by the late day weakness to end 2021.

Via Talk Markets

Three Stocks To Buy Now For 2022 ↗

January 02, 2022

Some investors thought it would never get here, but the

Via Talk Markets

Quidel’s Antigen Tests Detect the Omicron Variant

December 28, 2021

From Quidel Corporation

Via Business Wire

54 Biggest Movers From Thursday ↗

December 27, 2021

Gainers 22nd Century Group, Inc. (NASDAQ: XXII) surged 38.6% to settle at $3.05. The FDA authorized marketing of tobacco products that help reduce exposure to and consumption of...

Via Benzinga

Mid-Afternoon Market Update: Dow Surges 275 Points; SciPlay Shares Slide ↗

December 23, 2021

Toward the end of trading Thursday, the Dow traded up 0.77% to 36,030 while the NASDAQ rose 1% to 15,677. The S&P also rose, gaining 0.81% to 4,734.65. The U.S. has the...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 23, 2021

Gainers Pasithea Therapeutics (NASDAQ:

Via Benzinga

Quidel (QDEL) Stock Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Quidel Corporation is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – QDEL

December 23, 2021

From Halper Sadeh

Via Business Wire

OCDX Stock Alert: 9 Things to Know About the Quidel Deal Sending Ortho Clinical Higher ↗

December 23, 2021

Quidel will acquire OCDX stock for $24.68 per share and newly issued stock. The transaction will be worth a total of $6 billion.

Via InvestorPlace

Mid-Day Market Update: Nasdaq Rises 100 Points; Quidel Shares Plummet ↗

December 23, 2021

Midway through trading Thursday, the Dow traded up 0.62% to 35,975.34 while the NASDAQ rose 0.66% to 15,624.94. The S&P also rose, gaining 0.67% to 4,728.06. The U.S. has the...

Via Benzinga

38 Stocks Moving In Thursday's Mid-Day Session ↗

December 23, 2021

Gainers Pasithea Therapeutics Corp. (NASDAQ: KTTA) jumped 37.3% to $2.0182. Pasithea recently said it expanded its footprint with second Ketamine Therapy Clinic in the UK....

Via Benzinga

Tesla Leads Automobile Stocks to be Among Wednesday's Top Performers ↗

December 23, 2021

Stock index futures point higher as investors look to add to two days of gains. Thursday is the last trading day of the week because markets are closed on Friday in observance of...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 23, 2021

Gainers Pasithea Therapeutics (NASDAQ:KTTA) stock moved upwards by 27.89% to $1.88 during Thursday's pre-market session. The market value of their outstanding shares...

Via Benzinga

Quidel To Buy Ortho Clinical Diagnostics For $24.68/Share: Highlights ↗

December 23, 2021

Quidel Corp (NASDAQ: QDEL) has agreed to acquire Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) for $24.68 per share in cash and newly issued shares in...

Via Benzinga

Quidel Corporation Signs Definitive Agreement to Acquire Ortho Clinical Diagnostics

December 23, 2021

From Quidel Corporation

Via Business Wire

Free COVID Tests: What Stocks Will Benefit? ↗

December 23, 2021

The government hasn’t announced yet what company or companies it will be buying from, but there are several businesses involved in producing these kits.

Via Talk Markets

Biotech Playbook 2021 Part 2: Rotation Rally Brings Relief after FED Pivot ↗

December 22, 2021

The new aggressive Fed taper combined with a rise in interest rates for 2022 adds a new element of risk to portfolio management. Monetary policy is a headwind for 2022.

Via Talk Markets

COVID Testing Kit Makers Respond To Biden's Call For 500 Million Free At-Home Tests ↗

December 21, 2021

President Joe Biden announced his administration’s strategy for curbing the spread of the omicron variant of the coronavirus includes ordering 500 million at-home tests to...

Via Benzinga

QDEL Stock Alert: What Is Going on With Quidel Today? ↗

December 20, 2021

The nearing holidays mean an increasing demand for Covid-19 testing kits. Leading provider Quidel is seeing QDEL stock rise as a result.

Via InvestorPlace

Quidel Announces Sponsorship and Community Partnership With the Chicago Blackhawks

December 15, 2021

From Quidel Corporation

Via Business Wire

Series of Infographics From Quidel Corporation Helps Educate Consumers on the Characteristics, Warning Signs and Prevalence of Lyme Disease

December 14, 2021

From Quidel Corporation

Via Business Wire

Biotech Playbook 2021: No Help From Small Caps In Q4 ↗

December 14, 2021

Mid-cap stock picks have done better today but are way off their 2021 highs. Cryoport and Veracyte are still up and look better technically. Quidel was up 5.48% today on Omicron concerns globally but...

Via Talk Markets

7 Stocks to Buy to Hedge Against Omicron Variant Risks ↗

December 13, 2021

With the omicron variant presenting uncertainties regarding how governments will react, here are some stocks to buy to counter that risk.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

December 06, 2021

Gainers ACADIA Pharmaceuticals (NASDAQ:ACAD

Via Benzinga

The Daily Biotech Pulse: Adcom Backs Merck's Oral COVID-19 Treatment; Regulatory Setbacks For CTI Biopharma, BioXcel; Favorable Ruling For Viatris In Tecfidera Patent Case ↗

December 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Adcom Backing For Oral COVID-19 Antiviral Medication Molnupiravir...

Via Benzinga

Topics Intellectual Property

Quidel Statement on the Omicron Variant

November 30, 2021

From Quidel Corporation

Via Business Wire

Biotech Stocks are Due for a Rally ↗

November 22, 2021

There are many rebalancing trades left in your stock portfolio but biotech is in the doldrums.

Via Talk Markets

Quidel Presents at 33rd Annual Piper Sandler Healthcare Conference

November 19, 2021

From Quidel Corporation

Via Business Wire

Looking for Growth in Small and Mid Cap Life Science Stocks ↗

November 15, 2021

2021 is an unusual year for biotech with a “blow-off” February high in speculative small caps.

Via Talk Markets

< Previous 1 2

...

13 14 15 16 17 18 19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.